garenoxacin has been researched along with Febrile Neutropenia in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Fujita, S; Hata, A; Kaji, R; Katakami, N; Kitajima, N; Masuda, Y; Ose, T; Takashima, K; Takeshita, J; Tanaka, K | 1 |
| Kurokawa, M; Nakamura, F; Nannya, Y; Shinohara, A; Taoka, K; Uni, M; Yamazaki, S; Yoshimi, A | 1 |
2 other study(ies) available for garenoxacin and Febrile Neutropenia
| Article | Year |
|---|---|
[Comparison of garenoxacin and levofloxacin for the prophylaxis of febrile neutropenia].
Topics: Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Febrile Neutropenia; Female; Fluoroquinolones; Humans; Levofloxacin; Male; Middle Aged; Neoplasms; Retrospective Studies | 2014 |
Comparison of garenoxacin with levofloxacin as antimicrobial prophylaxis in acute myeloid leukemia.
Topics: Adult; Anti-Bacterial Agents; Antineoplastic Combined Chemotherapy Protocols; Bacteremia; Bacterial Infections; Febrile Neutropenia; Female; Fluoroquinolones; Humans; Leukemia, Myeloid, Acute; Levofloxacin; Male; Middle Aged; Primary Prevention; Retrospective Studies; Sample Size | 2015 |